A61P 35 - Antineoplastic agents

Patents for A61P 35 - Antineoplastic agents (221,099)
11/2006
11/15/2006	EP1495111A4 Novel methods for the in-vitro identification, isolation and differentiation of vasculogenic progenitor cells
11/15/2006	EP1474127B1 Biphenyl derivatives and their use as antiandrogenic agents
11/15/2006	EP1450799B1 Aryl urea compounds in combination with other cytostatic or cytotoxic agents for treating human cancers
11/15/2006	EP1423121B1 Cysteine protease inhibitors with 2-cyano-4-amino-pyrimidine structure and cathepsin k inhibitory activity for the treatment of inflammations and other diseases
11/15/2006	EP1414443B1 BENZIMIDAZO 4,5-f\|ISOQUINOLINONE DERIVATIVES
11/15/2006	EP1412383B1 Peptide conjugates, their derivatives with metal complexes and use thereof for magnetic resonance imaging (mri)
11/15/2006	EP1410040B1 Method for identifying substances which modulate interleukin 4 (il-4) signaling
11/15/2006	EP1406899B1 Phenylacetamido-thiazole derivatives, process for their preparation and their use as antitumor agents
11/15/2006	EP1324991B1 Compounds useful in the treatment of inflammatory diseases
11/15/2006	EP1309323B1 Treatment of angiogenesis-related disorders using benzoyl phenylacetic acid derivatives
11/15/2006	EP1244679B1 Purine derivatives
11/15/2006	EP1198560B1 Mammalian adhesion protease
11/15/2006	EP1064372B1 Compounds and methods for therapy and diagnosis of lung cancer
11/15/2006	EP1039921B1 Substantially pure histidine-linked protein polymer conjugates
11/15/2006	EP0968206B1 N-heterocyclic derivatives as nos inhibitors
11/15/2006	EP0931078B1 Novel tricyclic piperidinyl compounds useful as inhibitors of farnesyl-protein transferase
11/15/2006	CN1863818A Anti-VEGF antibodies
11/15/2006	CN1863817A Antibodies to M-CSF
11/15/2006	CN1863803A 嘧啶衍生物 Pyrimidine derivatives
11/15/2006	CN1863800A Novel compounds that modulate PPAR type receptors, and use thereof in cosmetic or pharmaceutical compositions
11/15/2006	CN1863796A Salts and polymorphs of a pyrrole-substituted indolinone compound
11/15/2006	CN1863792A Novel farnesyl protein transferase inhibitors as antitumor agents
11/15/2006	CN1863771A Sequence selective pyrrole and imidazole polyamide metallocomplexes
11/15/2006	CN1863545A Cytotoxic factors for modulating cell death
11/15/2006	CN1863508A Target-directed and enteric absorption-controlled liposome having sugar chain and cancer remedy and diagnostic containing the same
11/15/2006	CN1862258A Nucleolin assisted method for diagnosing and curing cancer
11/15/2006	CN1861630A Active segment of HER2/neu with Herstatin interaction, coding gene and application thereof
11/15/2006	CN1861627A 23-Hydroxyl betulinic acid kind derivant and preparing process, preparation and use thereof
11/15/2006	CN1861610A Synthesizing of Demethylcantharidin-neodymium
11/15/2006	CN1861605A Fleshy glossy ganoderma lactone A, preparation process and use thereof
11/15/2006	CN1861603A Silicon phthalocyanine compound and composite, their preparation and application thereof
11/15/2006	CN1861597A Internal ester monomer compound and its application in preparing anti cancer medicine
11/15/2006	CN1861588A Internal ester monomer compound and application in preparing anti cancer medicine
11/15/2006	CN1861587A Internal ester monomer compound and application in preparing anti cancer medicine
11/15/2006	CN1861558A Process of extracting cimitt acid
11/15/2006	CN1861201A Medical implant of sodium iodide and its prepn. method
11/15/2006	CN1861194A Anti gastrin-releasing peptide nucleic acid vaccine and its prepn. method
11/15/2006	CN1861192A Camptothecin type medicine loaded on high molecular nano-microsphere, and its prepn. method
11/15/2006	CN1861190A Application of anion exchange protein 1 and gene used as target for preparing medicine to treat alimentary canal tumor
11/15/2006	CN1861188A Aerosol contg. met-enkephalin
11/15/2006	CN1861140A Compound Chinese lobelia Tea agent and its prepn. method
11/15/2006	CN1861139A Prepn. method for compound Chinese lobelia liquid prepn. for external use
11/15/2006	CN1861138A Compound Chinese lobelia lozenge and its prepn. method
11/15/2006	CN1861137A Compound semisolid prepn. contg. Chinese lobelia for external use and its prepn. method
11/15/2006	CN1861127A Compound lobelia oral liquid prepn. and its prepn. method
11/15/2006	CN1861126A Compound lobelia oral solid prepn. and its prepn. method
11/15/2006	CN1861125A Prepn. method for compound lobelia fog-like prepn.
11/15/2006	CN1861103A Fatty-acid synthase inhibitor, its prepn. method, and medicine using same as active component
11/15/2006	CN1861101A Application of extractive of Hypericum sampsonii Hance to control RXR alpha acceptor target
11/15/2006	CN1861089A Prepn. of chlorofarabin and its prepn. method
11/15/2006	CN1861086A Pirarubicin emulsion composition
11/15/2006	CN1861078A Human AGT protein micromolecular inhibitor
11/15/2006	CN1861077A Beta-amino heterocyclic dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
11/15/2006	CN1861075A Injection use medicine composition contg. water-soluble 17-allylamino-17-demethoxy geldanamycin
11/15/2006	CN1861055A Composite slow-releasing anticarcinogen injection contg. platinum compounds
11/15/2006	CN1861054A Composite slow-releasing anticarcinogen contg. platinum compounds such as sunpla
11/15/2006	CN1861053A Slow-releasing injection contg. platinum compounds and cytotoxin type anticarcinogen
11/15/2006	CN1861052A Slow-releasing injection contg. platinum compound and cytotoxin type anticarcinogen
11/15/2006	CN1861051A Slow-releasing injection contg. platinum compounds and its potentiator type anticarcinogen
11/15/2006	CN1861050A Slow-releasing injection contg. platinum compounds and its potentiator type anticarcinogen
11/15/2006	CN1861049A Slow-releasing injection contg anticarcinogen of Jixitabin
11/15/2006	CN1861048A Slow-releasing injection contg. vasoinhibitor and cytotoxin type anticarcinogen
11/15/2006	CN1861047A Slow-releasing injection contg. vasoinhibitor and potentiator type anticarcinogen
11/15/2006	CN1861043A Ximite acid injection for anti-tumor and its prepn. method
11/15/2006	CN1861041A Temp-sensitive, slow-releasing gel used for local injection, and its prepn. method
11/15/2006	CN1860900A Tea with peony flower, and its prepn. method
11/15/2006	CN1284851C Somatic cell derived embryonic stem cell and its differentiated cell
11/15/2006	CN1284848C Dry red persimmon wine and its brewing method
11/15/2006	CN1284800C Highly sulfacted derivatives of K5 polysaccharide and their preparation
11/15/2006	CN1284798C Poly thymosin-alpha 1, its composition, its preparation method and application
11/15/2006	CN1284783C Substituted nitrogen contg. heterocycles as inhibitors of P38 progein kinase
11/15/2006	CN1284781C Polycyclic compounds having anti-tumor activity
11/15/2006	CN1284772C Benzamide kind histon deacetylase inhibiting agent having dissociation and antibred activity and its medicinal preparation
11/15/2006	CN1284599C Medicine for treating tumor and its preparation process
11/15/2006	CN1284597C Medicine for treating esophagus cancer
11/15/2006	CN1284587C Preparation of Chinese traditional medicine for treating tumor in alimentary canal
11/15/2006	CN1284545C Traditional Chinese medicine compound preparation for treating tumor and method for preparing the same
11/15/2006	CN1284543C Pharmaceutical preparation containing northeast cryrtominetin medicinal preparation and its new use
11/15/2006	CN1284542C Strengthened ganoderma lucidum for possible immunoprophylaxis and immunotherapy of cancers and related diseases as well as its preparing method
11/15/2006	CN1284539C Application of beta sodium aescine in preparation of medicine for treating leukemia
11/15/2006	CN1284537C Nimustine brain slow release implantation agent and its preparation method
11/15/2006	CN1284535C Application of liganans of biphenyl cyelo-octadiene in preparing antineoplastic medicine
11/15/2006	CN1284534C Aromatic turmeric oil extracts and its preparing process and medicinal composition containing the same
11/15/2006	CN1284522C Dextrose and insulin fluid formulation for intravenous infusion
11/14/2006	US7135587 Such as 3-biphenyl-4-yl-3-(2-(3-(pyridin-2-ylamino)pro-poxycarbonylamino) -ethanoylamino)propionic acid; thromboses, cardiac infarction, coronary heart disease, arteriosclerosis, inflammation, tumors. osteoporosis, infections, restenosis
11/14/2006	US7135572 Diaryl 1,2,4-triazole derivatives as a highly selective cyclooxygenase-2 inhibitor
11/14/2006	US7135568 Substituted pyrazolopyrimidines and thiazolopyrimidines
11/14/2006	US7135549 Can be used to elicit a humoral or cellular immune response; antibodies or T cells reactive with 184P1E2 can be used in active or passive immunization
11/14/2006	US7135502 Colchinol derivatives as vascular damaging agents
11/14/2006	US7135501 Clusianon isomers and use thereof
11/14/2006	US7135494 Antitumoral carbazoles
11/14/2006	US7135493 HDAC inhibitor
11/14/2006	US7135486 Substituted 2-thio-3,5-dicyano-4-aryl-6-aminopyridines and the use thereof
11/14/2006	US7135483 Substituted heterocyclic compounds for treating multidrug resistance
11/14/2006	US7135471 Aryl oximes
11/14/2006	US7135464 Method of administering decitabine
11/14/2006	US7135453 Reagents and methods for smooth muscle therapies
11/14/2006	US7135320 Adaptor protein FRS2 and related products and methods
11/14/2006	US7135301 Detection and treatment of prostate cancer
11/14/2006	US7135286 Pharmaceutical and diagnostic business systems and methods

1 ... 1135 1136 1137 1138 1139 1140 1141 1142 1143 1144 1145 1146 1147 1148 1149 1150 1151 1152 1153 1154 1155 ... 2211